ABT:NYE-Abbott Laboratories (USD)

EQUITY | Medical Devices | New York Stock Exchange

Last Closing

USD 114.99

Change

0.00 (0.00)%

Market Cap

USD 56.45B

Volume

2.83M

Analyst Target

USD 115.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Abbott Laboratories discovers, develops, manufactures and sells health care products. Its products include branded generic pharmaceuticals manufactured internationally, marketed and sold outside the United States.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
MDT Medtronic PLC

N/A

USD 103.90B
ZBH Zimmer Biomet Holdings Inc

N/A

USD 21.28B
STE STERIS plc

N/A

USD 20.53B
GMED Globus Medical

N/A

USD 11.25B
SNN Smith & Nephew SNATS Inc

N/A

USD 10.75B
PEN Penumbra Inc

N/A

USD 9.31B
BIO Bio-Rad Laboratories Inc

N/A

USD 9.17B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 9.16B
GKOS Glaukos Corp

N/A

USD 8.32B
INSP Inspire Medical Systems Inc

N/A

USD 5.63B

ETFs Containing ABT

UMDV:SW iShares US Medical Device.. 16.05 % 0.00 %

N/A

N/A
EDOC:AU BetaShares Digital Health.. 7.42 % 0.00 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 5.47 % 0.75 %

N/A

CAD 0.08B
HART IQ Healthy Hearts ETF 5.38 % 0.00 %

N/A

USD 9.55M
LIFE-U:CA Evolve Global Healthcare .. 5.05 % 0.00 %

N/A

N/A
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.68 % 0.00 %

N/A

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.60 % 0.00 %

N/A

USD 0.14B
XGES:LSE Xtrackers MSCI Genomic He.. 4.35 % 0.00 %

N/A

N/A
QLTY The 2023 ETF Series Trust.. 4.21 % 0.00 %

N/A

USD 1.44B
GDOC Goldman Sachs ETF Trust 3.94 % 0.00 %

N/A

USD 0.02B
IUHC:LSE iShares S&P 500 USD Healt.. 3.90 % 0.00 %

N/A

USD 2.15B
XLV Health Care Select Sector.. 3.88 % 0.13 %

N/A

USD 36.67B
SXLV:SW SPDR S&P U.S. Health Care.. 3.82 % 0.00 %

N/A

N/A
IUAE:CA Invesco S&P US Dividend A.. 3.73 % 0.00 %

N/A

CAD 1.21M
WELG:XETRA Amundi S&P Global Health .. 3.46 % 0.00 %

N/A

N/A
WELS:XETRA Amundi S&P Global Health .. 3.46 % 0.00 %

N/A

N/A
XUHC:SW 3.38 % 0.00 %

N/A

N/A
IUHC:SW iShares S&P 500 Health Ca.. 3.36 % 0.00 %

N/A

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.36 % 0.00 %

N/A

N/A
DRUG:AU BetaShares Global Healthc.. 3.34 % 0.00 %

N/A

USD 0.17B
FOHW:XETRA Franklin Future of Health.. 3.33 % 0.00 %

N/A

USD 2.68M
AIVL WisdomTree Trust - Wisdom.. 2.84 % 0.00 %

N/A

USD 0.40B
SPLV:SW iShares Edge S&P 500 Mini.. 2.83 % 0.00 %

N/A

USD 1.07B
HEAL:CA 2.82 % 0.00 %

N/A

N/A
WHEA:SW SPDR MSCI World Health Ca.. 2.68 % 0.00 %

N/A

N/A
VALQ American Century STOXX U... 2.57 % 0.29 %

N/A

USD 0.23B
2B78:F iShares Healthcare Innova.. 1.67 % 0.00 %

N/A

N/A
HEAL:SW iShares Healthcare Innova.. 1.63 % 0.00 %

N/A

N/A
HYLG Global X Funds - Global X.. 1.58 % 0.00 %

N/A

N/A
CURE Direxion Daily Healthcare.. 0.00 % 1.06 %

N/A

USD 0.17B
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

N/A

USD 2.62B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

N/A

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

N/A

N/A
QDYN 0.00 % 0.37 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

N/A

USD 5.03B
RWDC 0.00 % 0.00 %

N/A

N/A
GDNA 0.00 % 0.00 %

N/A

N/A
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

N/A

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

N/A

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

N/A

N/A
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

N/A

CAD 0.54B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

N/A

CAD 0.21B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

N/A
XGDD:LSE Xtrackers - Stoxx Global .. 0.00 % 0.00 %

N/A

N/A
XGSD:LSE Xtrackers Stoxx Global Se.. 0.00 % 0.00 %

N/A

N/A
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.61B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.61B
DXSB:F Xtrackers - Stoxx Global .. 0.00 % 0.00 %

N/A

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
XDWH:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

USD 2.60B
XUHC:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

USD 0.85B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

USD 0.40B
2B78:XETRA iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

USD 1.14B
DXSB:XETRA Xtrackers - Stoxx Global .. 0.00 % 0.00 %

N/A

USD 0.68B
IBCK:XETRA iShares Edge S&P 500 Mini.. 0.00 % 0.00 %

N/A

USD 1.49B
IS31:XETRA iShares Edge S&P 500 Mini.. 0.00 % 0.00 %

N/A

USD 0.11B
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

USD 2.05B
XDWH:XETRA Xtrackers MSCI World Heal.. 0.00 % 0.00 %

N/A

USD 2.60B
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.85B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

USD 0.40B
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

N/A

USD 1.40B
BMED BlackRock Future Health E.. 0.00 % 0.00 %

N/A

USD 4.16M
HHL-B:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

N/A

N/A
FUD-A:CA 0.00 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

N/A

CAD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.47% 65% D 52% F
Dividend Return 2.00% 71% C- 33% F
Total Return 6.47% 65% D 46% F
Trailing 12 Months  
Capital Gain 4.47% 65% D 52% F
Dividend Return 2.00% 71% C- 33% F
Total Return 6.47% 65% D 46% F
Trailing 5 Years  
Capital Gain 32.48% 63% D 67% D+
Dividend Return 10.78% 88% B+ 34% F
Total Return 43.26% 71% C- 64% D
Average Annual (5 Year Horizon)  
Capital Gain 3.11% 45% F 44% F
Dividend Return 4.55% 45% F 42% F
Total Return 1.44% 75% C 36% F
Risk Return Profile  
Volatility (Standard Deviation) 20.63% 90% A- 53% F
Risk Adjusted Return 22.05% 55% F 37% F
Market Capitalization 56.45B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 43.70 65% 19%
Price/Book Ratio 5.04 31% 19%
Price / Cash Flow Ratio 27.61 19% 12%
Price/Free Cash Flow Ratio 19.62 26% 19%
Management Effectiveness  
Return on Equity 14.84% 96% 75%
Return on Invested Capital 10.37% 93% 69%
Return on Assets 6.49% 96% 83%
Debt to Equity Ratio 35.23% 67% 69%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.